Transaction · 0001106578-26-000064

ROTHBLATT MARTINE A

ROTHBLATT MARTINE A, CHAIR, CEO, reported an open-market or private sale at UNITED THERAPEUTICS Corp involving 1638.000000 shares for an estimated $923307.35. Reported holdings after the transaction were 46560.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCHAIR, CEO
UTHRUNITED THERAPEUTICS Corp
Filing timeMay 29
Trade dateMay 28, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$556.82
Pre-filing
1mo ago +2.2%1w ago +1.6%1d ago +2.5%
Returns since
7d -1.2%30d -2.5%90d -6.9%180d -6.9%1y -6.9%

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2026-05-29Filed 99 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001106578-26-000064
Common Stock
Transaction date
May 28, 2026
Filed May 29, 2026, 08:37 PM · 1d delay
Shares
1.63k sh
$56.3k per share
Estimated value
-$92.3M
Computed from shares × price
Holdings after
46.5k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Sale Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chairperson & CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will c…

  2. F10

    This transaction was executed in multiple trades at prices ranging from $569.36 to $570.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  3. F11

    This transaction was executed in multiple trades at prices ranging from $570.41 to $571.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  4. F12

    This transaction was executed in multiple trades at prices ranging from $571.54 to $571.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  5. F13

    Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

  6. F14

    Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

  7. F15

    Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

  8. F16

    Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

  9. F2

    This transaction was executed in multiple trades at prices ranging from $561.00 to $561.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  10. F3

    This transaction was executed in multiple trades at prices ranging from $562.15 to $563.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  11. F4

    This transaction was executed in multiple trades at prices ranging from $563.16 to $564.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  12. F5

    This transaction was executed in multiple trades at prices ranging from $564.16 to $565.155. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…

  13. F6

    This transaction was executed in multiple trades at prices ranging from $565.25 to $566.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  14. F7

    This transaction was executed in multiple trades at prices ranging from $566.30 to $567.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  15. F8

    This transaction was executed in multiple trades at prices ranging from $567.31 to $568.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  16. F9

    This transaction was executed in multiple trades at prices ranging from $568.36 to $569.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

Original filing · 0001106578-26-000064
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR